Literature DB >> 20157402

Influence of ketamine on catecholamine secretion in the perfused rat adrenal medulla.

Young-Yeob Ko1, Yong-Hoon Jeong, Dong-Yoon Lim.   

Abstract

The aim of the present study was to examine the effects of ketamine, a dissociative anesthetics, on secretion of catecholamines (CA) secretion evoked by cholinergic stimulation from the perfused model of the isolated rat adrenal gland, and to establish its mechanism of action, and to compare ketamine effect with that of thiopental sodium, which is one of intravenous barbiturate anesthetics. Ketamine (30~300microM), perfused into an adrenal vein for 60 min, dose- and time-dependently inhibited the CA secretory responses evoked by ACh (5.32 mM), high K(+) (a direct membrane-depolarizer, 56 mM), DMPP (a selective neuronal nicotinic NN receptor agonist, 100microM) and McN-A-343 (a selective muscarinic M1 receptor agonist, 100microM). Also, in the presence of ketamine (100microM), the CA secretory responses evoked by veratridine (a voltage-dependent Na(+) channel activator, 100microM), Bay-K-8644 (an L-type dihydropyridine Ca(2+) channel activator, 10microM), and cyclopiazonic acid (a cytoplasmic Ca(2+)-ATPase inhibitor, 10microM) were significantly reduced, respectively. Interestingly, thiopental sodium (100microM) also caused the inhibitory effects on the CA secretory responses evoked by ACh, high K(+) , DMPP, McN-A-343, veratridine, Bay-K-8644, and cyclopiazonic acid. Collectively, these experimental results demonstrate that ketamine inhibits the CA secretion evoked by stimulation of cholinergic (both nicotinic and muscarinic) receptors and the membrane depolarization from the isolated perfused rat adrenal gland. It seems likely that the inhibitory effect of ketamine is mediated by blocking the influx of both Ca(2+) and Na(+) through voltage-dependent Ca(2+) and Na(+) channels into the rat adrenal medullary chromaffin cells as well as by inhibiting Ca(2+) release from the cytoplasmic calcium store, which are relevant to the blockade of cholinergic receptors. It is also thought that, on the basis of concentrations, ketamine causes similar inhibitory effect with thiopental in the CA secretion from the perfused rat adrenal medulla.

Entities:  

Keywords:  Adrenal medulla; Catecholamine secretion; Cholinergic receptors; Ketamine; thiopental

Year:  2008        PMID: 20157402      PMCID: PMC2817547          DOI: 10.4196/kjpp.2008.12.3.101

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  62 in total

1.  [Clinical studies on single-drug anesthesia using ketamine in patients with burns].

Authors:  R Klose; K Peter
Journal:  Anaesthesist       Date:  1973-03       Impact factor: 1.041

2.  Distribution in the brain and metabolism of ketamine in the rat after intravenous administration.

Authors:  M L Cohen; S L Chan; W L Way; A J Trevor
Journal:  Anesthesiology       Date:  1973-10       Impact factor: 7.892

3.  Studies of the mechanism of cardiovascular responses to CI-581.

Authors:  E G Dowdy; K Kaya
Journal:  Anesthesiology       Date:  1968 Sep-Oct       Impact factor: 7.892

4.  Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells.

Authors:  A Akaike; Y Mine; M Sasa; S Takaori
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

5.  Muscarinic receptor is coupled with a cation channel through a GTP-binding protein in guinea-pig chromaffin cells.

Authors:  M Inoue; H Kuriyama
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

6.  [The dual effect of ketamine on dopamine release from rat pheochromocytoma (PC-12) cells].

Authors:  T Okamoto; R Okutani; C Tashiro
Journal:  Masui       Date:  1996-09

7.  Sympathoadrenal responses to cold and ketamine anesthesia in the rhesus monkey.

Authors:  M A Kolka; R S Elizondo; R P Weinberg
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-04

8.  Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site.

Authors:  K Hara; N Yanagihara; K Minami; S Ueno; Y Toyohira; T Sata; M Kawamura; M Brüss; H Bönisch; A Shigematsu; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-09       Impact factor: 3.000

9.  Effects of ketamine on canine cardiovascular function.

Authors:  F A Diaz; J A Bianco; A Bello; N Beer; H Velarde; J P Izquierdo; R Jaen
Journal:  Br J Anaesth       Date:  1976-10       Impact factor: 9.166

10.  Calcium-induced calcium release mechanism in guinea pig taenia caeci.

Authors:  M Iino
Journal:  J Gen Physiol       Date:  1989-08       Impact factor: 4.086

View more
  2 in total

1.  The relation between the effect of a subhypnotic dose of thiopental on claw pain threshold in rats and adrenalin, noradrenalin and dopamine levels.

Authors:  Mehmet Aksoy; Ali Ahiskalioglu; Ilker Ince; Mine Celik; Aysenur Dostbil; Ufuk Kuyrukluyildiz; Durdu Altuner; Nezahat Kurt; Halis Suleyman
Journal:  Exp Anim       Date:  2015-07-22

2.  The effects of ketamine and thiopental used alone or in combination on the brain, heart, and bronchial tissues of rats.

Authors:  Elif Oral Ahiskalioglu; Pelin Aydin; Ali Ahiskalioglu; Bahadir Suleyman; Ufuk Kuyrukluyildiz; Nezahat Kurt; Durdu Altuner; Resit Coskun; Halis Suleyman
Journal:  Arch Med Sci       Date:  2016-06-06       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.